These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6046588)

  • 1. Effect of tranquilizers on the trail making test with chronic schizophrenics.
    Simon SH
    J Consult Psychol; 1967 Jun; 31(3):322-3. PubMed ID: 6046588
    [No Abstract]   [Full Text] [Related]  

  • 2. Temporal changes in handwriting size, level of premorbid social functioning and intellectural level during treatment in acute schizophrenics.
    Downing RW; Ebert JN; Boruchow JK; Valentine JH
    J Nerv Ment Dis; 1966 Jun; 142(6):526-33. PubMed ID: 5920205
    [No Abstract]   [Full Text] [Related]  

  • 3. Differentiation of schizophrenics with and without brain damage using the Whitaker Index of Schizophrenic Thinking.
    Puente AE; Sanders CH
    J Clin Psychol; 1981 Jul; 37(3):464-6. PubMed ID: 7263870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of clopenthixol in chronic schizophrenics.
    Sugerman AA; Lichtigfeld FJ; Herrmann J
    Curr Ther Res Clin Exp; 1966 May; 8(5):220-4. PubMed ID: 4956384
    [No Abstract]   [Full Text] [Related]  

  • 5. DIfferentiation of organics from schizophrenics with Reitan's sensory-perceptual disturbances tests.
    Watson CG; Thomas RW; Felling J; Andersen D
    Percept Mot Skills; 1968 Jun; 26(3):Suppl:1191-8. PubMed ID: 5675686
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of brain-damage in schizophrenics as measured by the Whitaker Index of Schizophrenic Thinking and the Luria-Nebraska Neuropsychological Battery.
    Puente AE; Heidelberg-Sanders C; Lund N
    Percept Mot Skills; 1982 Apr; 54(2):495-9. PubMed ID: 7079075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot study of SK&F 10812 in chronic schizophrenics.
    Sugerman AA; Lichtigfeld FJ
    Curr Ther Res Clin Exp; 1965 Nov; 7(11):707-11. PubMed ID: 4953691
    [No Abstract]   [Full Text] [Related]  

  • 8. Differential sorting behavior of schizophrenics and organics.
    Lovibond SH; Holloway I
    J Clin Psychol; 1968 Jul; 24(3):307-11. PubMed ID: 5661747
    [No Abstract]   [Full Text] [Related]  

  • 9. A preliminary study of Thiothixene in chronic schizophrenics.
    Simpson GM; Iqbal J
    Curr Ther Res Clin Exp; 1965 Nov; 7(11):697-700. PubMed ID: 4953690
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of non-brain-damaged schizophrenic and brain-damaged non-schizophrenic males on the WIST.
    Albott WL; Gilbert LG
    Psychol Rep; 1973 Feb; 32(1):187-94. PubMed ID: 4686065
    [No Abstract]   [Full Text] [Related]  

  • 11. Schizophrenic symptomatology as a function of probability of cerebral damage.
    Lilliston L
    J Abnorm Psychol; 1973 Dec; 82(3):377-81. PubMed ID: 4770909
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of Tybamate in chronic schizophrenia. (Minor tranquilizers as adjunct therapy in psychosis).
    Serafetinides EA; Clark ML
    Dis Nerv Syst; 1971 Aug; 32(8):567-71. PubMed ID: 5094163
    [No Abstract]   [Full Text] [Related]  

  • 13. Adherence to strong verbal meaning definitions in schizophrenics.
    Neuringer C; Fiske JP; Schmidt MW; Goldstein G
    J Genet Psychol; 1972 Dec; 121(2d Half):315-23. PubMed ID: 4650428
    [No Abstract]   [Full Text] [Related]  

  • 14. A comparison of the effects of oxypertine and trifluoperazine in withdrawn schizophrenics.
    Hunt PV
    Br J Psychiatry; 1967 Dec; 113(505):1419-24. PubMed ID: 4865294
    [No Abstract]   [Full Text] [Related]  

  • 15. Thiothixene (P-4657B): a controlled evaluation in chronic schizophrenic patients.
    Gallant DM; Bishop MP; Timmons E; Gould AR
    Curr Ther Res Clin Exp; 1966 Apr; 8(4):153-8. PubMed ID: 4956320
    [No Abstract]   [Full Text] [Related]  

  • 16. Differentiation of organics from schizophrenics with the trail making, dynamometer, critical flicker fusion, and light-intensity matching tests.
    Watson CG; Thomas RW; Felling J; Andersen D
    J Clin Psychol; 1969 Apr; 25(2):130-3. PubMed ID: 5789196
    [No Abstract]   [Full Text] [Related]  

  • 17. Discrimination of schizophrenics with and without nervous system damage using the Luria-Nebraska Neuropsychological Battery.
    Puente AE; Heidelberg-Sanders C; Lund NL
    Int J Neurosci; 1982 Feb; 16(1):59-62. PubMed ID: 7169277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of TPS-23 and thioridazine in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1965 Sep; 7(9):520-7. PubMed ID: 4953851
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of drug-free schizophrenics and controls.
    Narasimhachari N; Avalos J; Fujimori M; Himwich HE
    Biol Psychiatry; 1973 Dec; 5(3):311-8. PubMed ID: 4513564
    [No Abstract]   [Full Text] [Related]  

  • 20. The performance of brain-damaged and schizophrenic patients on the Minnesota Percepto-Diagnostic test under standard and BIP conditions of administration.
    Holland TR; Wadsworth HM; Royer FL
    J Clin Psychol; 1975 Jan; 31(1):21-5. PubMed ID: 1112897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.